TET2 and mature T-cell and NK-cell non-Hodgkin lymphoma: They observed multiple TET2 mutations (≥ 2) in 57% of AITL and PTCL-TFH cases; similar to our finding that nearly half of TET2-mutated cases had multiple mutations.